Largest international study of its kind finds new schizophrenia risk genes

Stephen Scherer
Stephen Scherer

Results of the International Psychiatric Genomics Consortium unveiled

TORONTO – Canadian and international scientists have uncovered six new schizophrenia risk genes in the largest study of its kind. The results of the international Psychiatric Genomics Consortium CNV working group are published in the Nov. 21 advance online edition of Nature Genetics, and further support the important role genes play in susceptibility to schizophrenia, and may be helpful in early diagnosis.

Continue reading

UBC scientists create a mouse that resists cocaine’s lure

Shernaz BamjiScientists at the University of British Columbia have genetically engineered a mouse that does not become addicted to cocaine, adding to the evidence that habitual drug use is more a matter of genetics and biochemistry than just poor judgment.

The mice they created had higher levels of a protein called cadherin, which helps bind cells together. In the brain, cadherin helps strengthen synapses between neurons – the gaps that electrical impulses must traverse to bring about any action or function controlled by the brain, whether it’s breathing, walking, learning a new task or recalling a memory.
Continue reading

An eye-catching result

Brian White
Brian White

Research determines how the brain recognizes what’s important at first glance.

Researchers at the Centre for Neuroscience Studies (CNS) at Queen’s University have discovered that a region of the brain – the superior colliculus – contains a mechanism responsible for interpreting how visual input from a scene determines where we look. This mechanism, known as a visual salience map, allows the brain to quickly identify and act on the most important information in the visual field, and is a basic mechanism for our everyday vision. Continue reading

New research shows how seizures can cause stroke-like events, which may be preventable

Cam Teskey
Cam Teskey

Scientists identify mechanism for brain dysfunction following seizures and drugs that prevent this impairment from occurring.

Six years ago, Cam Teskey, PhD, decided to follow a hunch. Armed with an advanced new tool designed to measure oxygen levels in tissues, he wanted to look at the brains of rats to see what was happening during seizures.  Continue reading

Lack of joy from music linked to brain disconnection

Dr. Robert Zatorre
Dr. Robert Zatorre

Have you ever met someone who just wasn’t into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.

Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of McGill University have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.
Continue reading

Breakthrough in MS treatment

Amit Bar-Or
Amit Bar-Or

Drug shown to reduce new attacks/symptom progression in some patients

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

Three studies conducted by an international team of researchers, which included Amit Bar-Or and Douglas Arnold from the Montreal Neurological Institute and Hospital of McGill University, have discovered that ocrelizumab can significantly reduce new attacks in patients with relapsing MS, as well as slow the progression of symptoms caused by primary progressive MS. Continue reading

An inherited form of intellectual disability, due to mutations in the SYNGAP1 gene, impairs connection of inhibitory neurons

Graziella Di Cristo and Jacques Michaud
Graziella Di Cristo and Jacques Michaud

Intellectual disability is characterized by significant impairment of cognitive and adaptive functions and affects 1-3 in 100 individuals worldwide. A few years ago, scientists at CHU Ste.Justine reported for the first time that genetic mutations in the gene SYNGAP1 cause a form of intellectual disability, which is often associated with autism spectrum disorders and epilepsy. Since then, DNA sequencing of SYNGAP1 in several groups of individuals with intellectual disability in Canada, the US and Europe has revealed that pathogenic mutations in SYNGAP1 are one of the most common cause of genetic intellectual disability. Continue reading

McMaster Scientists Discover Autism Gene Slows Down Brain Cell Communication

Karun Singh

Scientists at McMaster University’s Stem Cell and Cancer Research Institute in collaboration with Sick Children’s Hospital have discovered genetic alterations in the gene DIXDC1 in individuals with autism spectrum disorders (ASD). This gene was found to change the way brain cells grow and communicate.

This finding, published today in Cell Reports, provides new insights into ASD that will guide identification of new medications for people with ASD. This is critical because ASD affects one in 68 individuals, and there are no medications that target the core symptoms of this complex disorder. Continue reading

Researchers at Université Laval identify a mechanism that leads to the death of neurons in Parkinson’s disease

Martin LévesqueIt is known that neurodegenerative diseases such as Parkinson’s cause the gradual death of brain neurons. But what exactly are the mechanisms that go awry to cause degeneration of nerve cells? A team of researchers from Université Laval and the Quebec Mental Health Research Institute investigated the matter and show, in an article in Proceedings of the National Academy of Sciences (PNAS), the role played by two key regulatory proteins in the cascade of reactions leading to the death of neurons in Parkinson’s disease. Continue reading

Gaming camera could aid MS treatment

3D depth-sensing camera shown to measure walking difficulties

A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.

The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.

A team of researchers led by McGill University postdoctoral fellow Farnood Gholami, supervised by Jozsef Kövecses from the Department of Mechanical Engineering and Centre for Intelligent Machines, collaborated with Daria Trojan, a physiatrist in the Department of Neurology and Neurosurgery working at the Montreal Neurological Institute and Hospital, to test whether the Kinect could detect the differences in gait of MS patients compared to healthy individuals. Continue reading